# Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

> **NCT01683955** · PHASE1 · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 139 (actual)

## Conditions studied

- Acute Blood Loss Anemia
- Osteoarthritis, Hip

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01683955
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-01
- **Primary completion:** 2013-11-03
- **Final completion:** 2013-11-03
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2023-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01683955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01683955, "Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01683955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*